VIKTANA is pan genotypic anti-viral drug that contains 400mg of Sofosbuvir and 100mg of Velpatasvir. It is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 without cirrhosis or with compensated cirrhosis or with decompensated cirrhosis in combination with Ribavirin. VIKTANA tablets are available in white color HDPE bottle having 28 film coated tablets.